View Shlomo Greenberg's Articles BY TICKER:
ALDN, ALJ, ALVR, ANSW, AUDC, BOSC, BPA, BWEBF, CALL, CHKP, CIMT, CKSW, CMVT, CYRN, DDDC, DOX, DSPG, ECIL, ECTX, ELOS, ELRN, ELTK, EMITF, ESLT, EZCH, FLSH, GILT, HCTL, IXMO, MAT, MDSY, MDT, MGIC, MTLK, NNDS, NSTC, OMRI, ORA, ORBK, OTIV, PARS, PNTR, ROSG, RTLX, RVSN, SCOP, SFUN, SILC, SVNTQ, TARO, TATT, TEVA, TFR, TSEM, TTIL, VYYO, WILC, ZRAN
- DSPG: Will Monday's Deal Herald A Breakthrough?
- Analysts Catching On Only Now, But Teva Has Always Been Heading North
- Taro Pharmaceutical: One for Speculators
- Sidelining Saifun: No Pleasant Surprises, But I'm Following It Closely
- Chairman Makov Rises to the Given Imaging Challenge
- Ormat: Time Will Tell Whether the Warning Was A One-time Event
- Why Are Analysts Lukewarm on Check Point?
- Zeroing In On Zoran: A Company Capable of Holding Its Own
- Everybody's Getting High on Pharmos, But The Stampede Is No Hint to Hold
- Taro Pharmaceutical: A Bargain May Be Beckoning
- Alvarion: Sentiment Progressively More Positive, And With Good Reason
- BluePhoenix: On The Rise
- TAT's Solid Growth Expected to Continue
- Commtouch: A Speculative Stock With Strong Management
- ECI Telecom: Wait on the Sidelines
- Pointer Telocation: Investment by Three Reputable Institutions Is Telling
- Protalix BioTherapeutics: This Dream Could Take Time to Manifest
- Alon USA Energy: It's All About the Management
- AudiCodes: VoIP May Be in Freefall, But This Stock Should Get a Second Look
- Elbit Medical Imaging: A Supplier of Dreams
Ampal-American Israel Corporation: Ample Opportunity to Soar
Apr. 9, 2007 • Comment!
- Rosetta Genomics: Can This Dream Team Woo Wall Street?
- Cimatron's Connection: Stock Soared Following Foray into China
- Retalix: Deal with British Petroleum is Tribute to the Company's Vision
- Eltek: Price Levels That Demand Attention
- Comverse: Price Levels That Demand Attention
- The Burden of Proof Is On Vyyo
- The Long Case for Deltathree: Stock Looks Cheap Compared to Performance
- A Mysterious Changing of the Guard: Is There Something ECtel's Not Telling?
- Teva: Making a Foray into Biogenerics?
- Silicom Makes Its Quantum Leap
- Elbit Systems: Ongoing Privatization Should Lead It to Victory